LOS ANGELES, March 6, 2014 /PRNewswire/ -- Verde Media
Biotechnology Division ("VMBD") is in the advance negotiation stage
for acquisition and partnership with a Massachusetts based technology-developing
company for the production of high value bio-products. The target
company has developed a microbial technology platform for the
production of omega-3 fatty acids (EPA and DHA) using economical
and abundantly available feedstock. The alternative fermentation
based process can convert sugars and organic waste products to
omega-3 oils with high yields and specificity and therefore open
new supply chains. Furthermore, the process is capable of producing
high titre and concentration of omega-3 oils in the fermentation
vessel.
The new platform technologies can achieve 500-800% increase in
DHA levels in the microbial oils compared to fish derived oils. As
a result, the microbial derived omega-3 oils have a niche place in
the several billion-dollar cosmetic and medicinal markets. The
development is in line with an increasing trend in demand mainly in
the aquaculture industry ($100
billion) and food supplements ($30B).
Dr. Abidi, Ph.D. CEO of VMBD stated, "We are excited with the
addition of another high value bio-product to our growing portfolio
of acquisition targets. The ability to convert sugar and non-sugar
feedstock to omega-3 oil is more efficient than converting carbon
dioxide gas to oils and provides a competitive advantage to all
other technologies. Furthermore, carbohydrate to omega-3 oil is a
sustainable, renewable and eco-friendly process that can be rapidly
scaled-up to commercial production."
About Verde Media Group Inc.
Verde Media Group Inc. is a publicly traded company listed on
the OTC Markets trading under the stock symbol: VMGI. Verde
Media Group Inc. The company is consists of three divisions:
Agency Division- The innovative Agency division services-
public relations, marketing, and transaction functions for
corporate clientele. The agency is rapidly expanding its business
in the Denver, Colorado market
that will become the largest retail marijuana sector currently
legitimized.
BioTech Division- The VMBD division undertakes the business of
developing and producing high value bio-products from renewable
biomass. The focus and criterion is to develop proprietary
microbial technologies with low risk scale-up methods employing low
cost feedstock. VMBD will further develop the derivative and ester
forms of THC for increase potency and their use in different
delivery systems, including sublingual, inhaled dosage forms and
blending with food products.
Entertainment Division- The company operates a managed
media company with production, distribution, development, and
acquisition functions for film and television.
For more information, visit www.verdemediagroup.com, or connect
with the company on Facebook.
DISCLAIMER: CAUTIONARY DISCLOSURE ABOUT FORWARD-LOOKING
STATEMENTS
The results described herein cannot be guaranteed. This release
contains "forward-looking statements" within the meaning of Section
27A of the Securities Act of 1933, as amended, and Section 21E the
Securities Exchange Act of 1934, as amended and such
forward-looking statements are made pursuant to the safe harbor
provisions of the Private Securities Litigation Reform Act of 1995.
Statements in this news release other than statements of historical
fact are "forward-looking statements" that are based on current
expectations and assumptions.
Logo: http://photos.prnewswire.com/prnh/20140219/PH68218LOGO
SOURCE Verde Media Group, Inc.